These three diabetes stocks have a lot going on this month.
News & Analysis: Eli Lilly and Company
New blockbusters could be on the way for five drugmakers.
Which stock wins in a battle between these two big drugmakers?
And the analyst really likes one in particular.
Which stock wins in a matchup between these two big drugmakers?
These three diabetes stocks should be on your radar right now.
LLY earnings call for the period ending March 31, 2019.
The big drugmaker missed Wall Street revenue expectations in Q1 but narrowly beat earnings estimates. Here's what you need to know.
Eli Lilly and GlaxoSmithKline are both pharma royalty. Which stock is the better buy right now?
AbbVie and Eli Lilly are two rock-solid dividend plays, but only one is a buy right now.